Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin
Sally E de Zwaan1, Harry J Iland, Diona L Damian
1Department of Dermatology, Royal Prince Alfred Hospital, New South Wales, Australia. sallydz@hotmail.com
Abstract:
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Venous Thrombosis III: Interprofessional Care

